Quantitative Atlas of Blood–Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset

Cited by (259)

Items 101–200 of 259

1. Designing the future of nanomedicine: current barriers to targeted brain therapeutics
   Luciana M. Herda, Ester Polo, Philip M. Kelly, Louise Rocks, Diána Hudecz, Kenneth A. Dawson · 2014 · European Journal of Nanomedicine
2. A guide for blood–brain barrier models
   Yomna Soliman, Jana Al‐khodor, Gulnaz Yildirim Koken, Nur Mustafaoğlu · 2024 · FEBS Letters
3. Efficient isolation of brain capillary from a single frozen mouse brain for protein expression analysis
   Seiryo Ogata, Shingo Ito, Takeshi Masuda, Sumio Ohtsuki · 2020 · Journal of Cerebral Blood Flow & Metabolism
4. Electrospun Scaffolds as Cell Culture Substrates for the Cultivation of an In Vitro Blood–Brain Barrier Model Using Human Induced Pluripotent Stem Cells
   Felix Rohde, Karin Danz, Nathalie Jung, Sylvia Wagner, Maike Windbergs · 2022 · Pharmaceutics
5. Chlorpyrifos, permethrin and cyfluthrin effect on cell survival, permeability, and tight junction in an in-vitro model of the human blood-brain barrier (BBB)
   Deepika Deepika, Saurav Kumar, Natalia Bravo, Roser Esplugas, Marco Capodiferro, Raju Prasad Sharma, Marta Schuhmacher, Joan O. Grimalt, Jordi Blanco, Vikas Kumar · 2022 · NeuroToxicology
6. Impact of CNS Diseases on Drug Delivery to Brain Extracellular and Intracellular Target Sites in Human: A “WHAT-IF” Simulation Study
   Mohammed A. A. Saleh, Elizabeth C. M. de Lange · 2021 · Pharmaceutics
7. IgG Fusion Proteins for Brain Delivery of Biologics via Blood–Brain Barrier Receptor-Mediated Transport
   Rubén J. Boado · 2022 · Pharmaceutics
8. Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation
   Stéphanie Chasseigneaux, Véronique Cochois, Lucas Lecorgne, Murielle Lochus, Sophie Nicolic, Corinne Blugeon, Laurent Jourdren, David Gomez‐Zepeda, Stefan Tenzer, Sylvia Sanquer et al. · 2024 · Fluids and Barriers of the CNS
9. Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood–Brain Barrier
   Catarina Chaves, David Gomez‐Zepeda, Sylvain Auvity, Marie‐Claude Menet, Dominique Crété, Laurence Labat, Fernando Remião, Salvatore Cisternino, Xavier Declèves · 2015 · Journal of Pharmaceutical Sciences
10. Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review
    Sajjad Muhammad, Shafqat Rasul Chaudhry, Ulf D. Kahlert, Martin Lehečka, Miikka Korja, Mika Risto Niemela, Daniel Hänggi · 2020 · International Journal of Molecular Sciences
11. Modelling the Human Blood–Brain Barrier in Huntington Disease
    Domenico Vignone, Odalys Gonzalez Paz, Ivan Fini, Antonella Cellucci, Giulio Auciello, Maria Rosaria Battista, Isabelle Gloaguen, Silvia Fortuni, Cristina Cariulo, Vinod K. Khetarpal et al. · 2022 · International Journal of Molecular Sciences
12. Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
    Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yanyan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi et al. · 2017 · Drug Metabolism and Disposition
13. LC–MS/MS-based quantification of efflux transporter proteins at the BBB
    David Gomez‐Zepeda, Méryam Taghi, Maria Smirnova, Philippe Sergent, Wang‐Qing Liu, Cérina Chhuon, Michel Vidal, Martin Picard, Elizabeth Thioulouse, Isabelle Broutin et al. · 2018 · Journal of Pharmaceutical and Biomedical Analysis
14. The Brain Exposure Efficiency (BEE) Score
    Mayuri Gupta, Thomas Bogdanowicz, Mark A. Reed, Christopher Barden, Donald Fredric Weaver · 2019 · ACS Chemical Neuroscience
15. Glutamate Transporters in the Blood-Brain Barrier
    Hans Christian Cederberg Helms, Carsten Uhd Nielsen, Helle S. Waagepetersen, Birger Brodin · 2017 · Advances in neurobiology
16. Polarized hemichannel opening of pannexin 1/connexin 43 contributes to dysregulation of transport function in blood-brain barrier endothelial cells
    Masanori Tachikawa, Koji Murakami, Ryo Akaogi, Shin‐ichi Akanuma, Tetsuya Terasaki, Ken‐ichi Hosoya · 2019 · Neurochemistry International
17. Comparing translational population‐PBPK modelling of brain microdialysis with bottom‐up prediction of brain‐to‐plasma distribution in rat and human
    Kathryn Ball, François Bouzom, Jean‐Michel Scherrmann, Bernard Walther, Xavier Declèves · 2014 · Biopharmaceutics & Drug Disposition
18. Understanding the rules of the road: proteomic approaches to interrogate the blood brain barrier
    Bruce Edward Torbett, Andrew Baird, Brian P. Eliceiri · 2015 · Frontiers in Neuroscience
19. Methods to optimize CNS exposure of drug candidates
    Nandini C. Patel · 2020 · Bioorganic & Medicinal Chemistry Letters
20. Protein Expression of Amino Acid Transporters Is Altered in Isolated Cerebral Microvessels of 5xFAD Mouse Model of Alzheimer’s Disease
    Elena Puris, Liudmila Saveleva, Izaque de Sousa Maciel, Katja M. Kanninen, Seppo O. K. Auriola, Gert Fricker · 2022 · Molecular Neurobiology
21. Cognition in movement disorders: Where can we hope to be in ten years?
    David John Burn, Daniel A. Weintraub, Bernard M. Ravina, Irene Litvan · 2014 · Movement Disorders
22. Recent advances in the in vitro and in vivo methods to assess impact of P‐glycoprotein and breast cancer resistance protein transporters in central nervous system drug disposition
    Sagnik Chatterjee, Anup Arunrao Deshpande, Hong Shen · 2023 · Biopharmaceutics & Drug Disposition
23. Interspecies Brain PBPK Modeling Platform to Predict Passive Transport through the Blood–Brain Barrier and Assess Target Site Disposition
    Parsshava Mehta, Amira Soliman, Leyanis Rodríguez‐Vera, Stephan Schmidt, Paula Muniz, Mónica Rodríguez, Marta Forcadell, Emili Gonzalez-Perez, Valvanera Vozmediano · 2024 · Pharmaceutics
24. 3D in vitro blood–brain barrier models: recent advances and their role in brain disease research and therapy
    Laura O’Halloran, Olutoyosi Akinsete, A. Leah Kogan, Michelle Wrona, Amira F. Mahdi · 2025 · Frontiers in Pharmacology
25. Harnessing Preclinical Data as a Predictive Tool for Human Brain Tissue Targeting
    Nandini C. Patel, Bo Feng, Xinjun Hou, Mark A. West, Patrick E. Trapa, Simone Sciabola, Patrick R. Verhoest, Jennifer L. Liras, Tristan S. Maurer, Travis T. Wager · 2021 · ACS Chemical Neuroscience
26. Treatment with outgrowth endothelial cells protects cerebral barrier against ischemic injury
    Rais Reskiawan A. Kadir, Mansour Alwjwaj, Ulvi Bayraktutan · 2022 · Cytotherapy
27. The ABCG2 Multidrug Transporter
    Agnès Basseville, Matthew D. Hall, Cindy H. Chau, Robert W. Robey, Michael M. Gottesman, William Douglas Figg, Susan Elaine Bates · 2015 · Springer eBooks
28. Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities
    Sho Sato, Kimio Tohyama, Yohei Kosugi · 2019 · European Journal of Pharmaceutical Sciences
29. Stem Cell Based Preclinical Drug Development and Toxicity Prediction
    Dhruv Kumar, Prakash Baligar, Rajpal Srivastav, Priyanka Narad, Sibi Raj, Chanderdeep Tandon, Simran Tandon · 2020 · Current Pharmaceutical Design
30. A Human Brain-Chip for Modeling Brain Pathologies and Screening Blood–Brain Barrier Crossing Therapeutic Strategies
    Shek Man Chim, Kristen Howell, Alexandros G. Kokkosis, Brian Zambrowicz, Katia P. Karalis, Elias Pavlopoulos · 2024 · Pharmaceutics
31. Targeted unlabeled multiple reaction monitoring analysis of cell markers for the study of sample heterogeneity in isolated rat brain cortical microvessels
    David Gomez‐Zepeda, Catarina Chaves, Méryam Taghi, Philippe Sergent, Wang‐Qing Liu, Cérina Chhuon, Michel Vidal, Martin Picard, Elizabeth Thioulouse, Isabelle Broutin et al. · 2017 · Journal of Neurochemistry
32. Proteome of the Luminal Surface of the Blood–Brain Barrier
    Jennifer J. Hill, Arsalan S. Haqqani, Danica B Stanimirovic · 2021 · Proteomes
33. Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [11C]-N-desmethyl-loperamide PET study in nonhuman primates
    Annelaure Damont, Sébastien Goutal, Sylvain Auvity, Héric Valette, Bertrand Kühnast, Wadad Saba, Nicolas Tournier · 2016 · European Journal of Pharmaceutical Sciences
34. Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human
    Yin Cheong Wong, Maddalena Centanni, Elizabeth C. M. de Lange · 2019 · The Journal of Clinical Pharmacology
35. Probenecid Increases the Concentration of 7-Chlorokynurenic Acid Derived from the Prodrug 4-Chlorokynurenine within the Prefrontal Cortex
    Waseema Patel, Lara Jane Rimmer, Martin Smith, Lucie Moss, Mark A. Smith, H. Ralph Snodgrass, Munir Pirmohamed, Ana Alfirevic, David Dickens · 2020 · Molecular Pharmaceutics
36. Brain Penetration of WEB 2086 (Apafant) and Dantrolene in Mdr1a (P-Glycoprotein) and Bcrp Knockout Rats
    Holger Fuchs, Wataru Kishimoto, Dietmar Ganßer, Paul Tanswell, Naoki Ishiguro · 2014 · Drug Metabolism and Disposition
37. Proteome profile differences among human, monkey, and mouse brain microvessels and cultured brain microvascular endothelial cells
    Haruka Kumabe, Takeshi Masuda, Shingo Ito, Tomomi Furihata, Akiko Toda, M. Mogi, Norie Araki, S. Ohtsuki · 2025 · Fluids and Barriers of the CNS
38. Non-Human Primate Blood–Brain Barrier and In Vitro Brain Endothelium: From Transcriptome to the Establishment of a New Model
    C. Chaves, T. Do, Céline Cegarra, V. Roudières, Sandrine Tolou, G. Thill, Corinne Rocher, M. Didier, D. Lesuisse · 2020 · Pharmaceutics
39. Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofen
    Emma E.J. Kasteel, L.S. Lautz, Maxime Culot, Nynke I. Kramer, Anne Zwartsen · 2021 · Toxicology in Vitro
40. Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics
    Zaril Harza Zakaria, Raj Kumar Singh Badhan · 2018 · Pharmaceutics
41. Muscle to Brain Partitioning as Measure of Transporter-Mediated Efflux at the Rat Blood–Brain Barrier and Its Implementation into Compound Optimization in Drug Discovery
    Yunhai Cui, Ralf R.H. Lotz, Hermann Rapp, Klaus Klinder, Anneke Himstedt, Achim Sauer · 2019 · Pharmaceutics
42. Optimization of dose and route of administration of the P‐glycoprotein inhibitor, valspodar (PSC‐833) and the P‐glycoprotein and breast cancer resistance protein dual‐inhibitor, elacridar (GF120918) as dual infusion in rats
    Christopher Rowbottom, Alicia Pietrasiewicz, Taras Tuczewycz, Richard Grater, Daniel Qiu, Sudarshan Kapadnis, Patrick E. Trapa · 2021 · Pharmacology Research & Perspectives
43. The Blood-Brain Barrier: Implications for Experimental Cancer Therapeutics
    Joelle P. Straehla, David A. Reardon, Patrick Yung Wen, Nathalie Y.R. Agar · 2023 · Annual Review of Cancer Biology
44. A face‐to‐face comparison of the BBB cell models hCMEC / D3 and hBMEC for their applicability to adenoviral expression of transporters
    Valerio Taggi, Anima M. Schäfer, Asaél Dolce, Henriette E. Meyer zu Schwabedissen · 2024 · Journal of Neurochemistry
45. Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio
    Johan Nicolaï, Hélène Chapy, Eric Gillent, Kenneth C. Saunders, Anna-Lena B. Ungell, Jean-Marie Nicolas, Hugues Chanteux · 2020 · Pharmaceutical Research
46. Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(−/−) rats
    Yoko Nagaya, Yoshitane Nozaki, Osamu Takenaka, Ryuji Watari, Kazutomi Kusano, Tsutomu Yoshimura, Hiroyuki Kusuhara · 2015 · Drug Metabolism and Pharmacokinetics
47. Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity
    Jean-Marie Nicolas, Elizabeth C. M. de Lange · 2019 · The AAPS Journal
48. Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier
    Rubén J. Boado · 2025 · RSC Pharmaceutics
49. Assessing extent of brain penetration in vivo (Kp,uu,brain) in Göttingen minipig using a diverse set of reference drugs
    Kristine Langthaler, Christopher R. Jones, Birger Brodin, Christoffer Bundgaard · 2023 · European Journal of Pharmaceutical Sciences
50. A Practical Perspective on the Evaluation of Small Molecule CNS Penetration in Drug Discovery.
    Li-Yue Huang, Mary C. Wells, Zhi-Yang Zhao · 2020 · Drug Metabolism Letters
51. In Vitro Cell Models of the Human Blood-Brain Barrier: Demonstrating the Beneficial Influence of Shear Stress on Brain Microvascular Endothelial Cell Phenotype
    Keith D. Rochfort, Philip M. Cummins · 2018 · Neuromethods
52. Seizures triggered by pentylenetetrazol in marmosets made chronically epileptic with pilocarpine show greater refractoriness to treatment
    Josy Carolina Covan Pontes, Thiago Z. Lima, Claudio Marcos Queiroz, Simone M. Cinini, Miriam Marcela Blanco, Luiz E. Mello · 2016 · Epilepsy Research
53. From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics
    Tanaka, Masaru, Araujo, Adriano Cressoni, Valenti, Vítor Engrácia, Guiguer, Elen Landgraf, Catharin, Vitor Cavallari Strozze, Gualhardi, Cristiano Machado, de Souza Bastos Mazuqueli Pereira, Eliana, de Alvares Goulart, Ricardo, de Argolo Haber, Rafael Santos, de Carvalho, Atonelly Cassio Alves et al. · 2026 · International Journal of Molecular Sciences
54. Microfluidic-Based Technologies for Crossing the Blood–Brain Barrier Against Alzheimer’s Disease: Novel Strategies and Challenges
    Irene Ferrari, Emanuele Limiti, Sara Maria Giannitelli, Marcella Trombetta, Alberto Rainer, Marcello D’Amelio, Livia La Barbera, Manuele Gori · 2025 · International Journal of Molecular Sciences
55. Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences
    Fanchon Bourasset, Sylvain Auvity, Robert G. Thorne, Jean‐Michel Scherrmann · 2020 · Handbook of experimental pharmacology
56. Species Differences and Impact of Disease State on BBB
    Jean‐Marie Nicolas · 2015
57. Modeling the Blood–Brain Barrier to Understand Drug Delivery in Alzheimer’s Disease
    Joanna Marta Wasielewska, J. Chaves, Anthony Robert White, Lotta E. Oikari · 2020 · Exon Publications eBooks
58. Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates
    Sébastien Goutal, Oliver Langer, Sylvain Auvity, Karine Andrieux, Christine Coulon, Fabien Caillé, Philippe Gervais, Salvatore Cisternino, Xavier Declèves, Nicolas Tournier · 2018 · Drug Delivery and Translational Research
59. Engineering Organoids for in vitro Modeling of Phenylketonuria
    Alice C. Borges, Kerensa Broersen, Paula Leandro, Tiago G. Fernandes · 2022 · Frontiers in Molecular Neuroscience
60. Boron Delivery to Brain Cells via Cerebrospinal Fluid (CSF) Circulation for BNCT in a Rat Melanoma Model
    Sachie Kusaka, Yuri Morizane, Yugo Tokumaru, Shingo Tamaki, Indah Rosidah Maemunah, Yoko Akiyama, Fuminobu Sato, Isao Murata · 2022 · Biology
61. Cerebrospinal fluid-based boron delivery system may help increase the uptake boron for boron neutron capture therapy in veterinary medicine: A preliminary study with normal rat brain cells
    Sachie Kusaka, Yuri Morizane, Yugo Tokumaru, Shingo Tamaki, Indah Rosidah Maemunah, Yoko Akiyama, Fuminobu Sato, Isao Murata · 2022 · Research in Veterinary Science
62. A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurement
    Johid R. Malik, Courtney Vail Fletcher, Anthony T. Podany, Shetty Ravi Dyavar, Kimberly K. Scarsi, Gwendolyn M. Pais, Marc H. Scheetz, Sean N. Avedissian · 2023 · Journal of Neuroscience Methods
63. [11C]befloxatone brain kinetics is not influenced by Bcrp function at the blood–brain barrier: A PET study using Bcrp TGEM knockout rats
    Benoît Hosten, Raphaël Boisgard, Aude Jacob, Sébastien Goutal, Bruno Saubaméa, Frédéric Dollé, Jean‐Michel Scherrmann, Salvatore Cisternino, Nicolas Tournier · 2013 · European Journal of Pharmaceutical Sciences
64. In vitro and in vivo evaluations of the P-glycoprotein-mediated efflux of dibenzoylhydrazines
    Kenichi Miyata, Yoshiaki Nakagawa, Yasuhisa Kimura, Kazumitsu Ueda, Miki Akamatsu · 2016 · Toxicology and Applied Pharmacology
65. Quantitative Proteomics-Based Blood–Brain Barrier Study
    Yasuo Uchida · 2021 · Biological and Pharmaceutical Bulletin
66. Direct Comparison of the Prediction of the Unbound Brain-to-Plasma Partitioning Utilizing Machine Learning Approach and Mechanistic Neuropharmacokinetic Model
    Yohei Kosugi, Kunihiko Mizuno, Cipriano Santos, Sho Sato, Natalie A. Hosea, Michael A. Zientek · 2021 · The AAPS Journal
67. Reproducibility in biological models of the blood-brain barrier
    Diána Hudecz, Louise Rocks, Laurence W. Fitzpatrick, Luciana M. Herda, Kenneth A. Dawson · 2014 · European Journal of Nanomedicine
68. [18F]Altanserin and small animal PET: Impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT2A receptor densities in the rat brain
    Tina Kroll, David Elmenhorst, Andreas Matusch, Abdullah Çelik, Franziska Wedekind, Angela Weisshaupt, Simone Beer, Andreas Bauer · 2013 · Nuclear Medicine and Biology
69. Practical Application of Rodent Transporter Knockout Models to Assess Brain Penetration in Drug Discovery
    Elin Eneberg, Christopher R. Jones, Thomas N. Jensen, Kristine Langthaler, Christoffer Bundgaard · 2022 · Drug Metabolism and Bioanalysis Letters
70. Selective Protein Expression Changes of Leukocyte-Migration-Associated Cluster of Differentiation Antigens at the Blood–Brain Barrier in a Lipopolysaccharide-Induced Systemic Inflammation Mouse Model without Alteration of Transporters, Receptors or Tight Junction-Related Protein
    Kazuki Sato, Masanori Tachikawa, Michitoshi Watanabe, Yasuo Uchida, Tetsuya Terasaki · 2019 · Biological and Pharmaceutical Bulletin
71. Mass Spectrometry of Human Transporters
    Brahim Achour, Zubida M. Al‐Majdoub, Amin Rostami‐Hodjegan, Jill Barber · 2020 · Annual Review of Analytical Chemistry
72. In Vitro Blood-Brain Barrier Models for Neuroinfectious Diseases: A Narrative Review
    Ahmad Hussein Jumah Badawi, Nur Afiqah Mohamad, Johnson Stanslas, Brian Patrick Kirby, Vasantha Kumari Neela, Rajesh Ramasamy, Hamidon Basri · 2023 · Current Neuropharmacology
73. Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context
    Xue Mi, Zi-Ling Ye, Xujun Zhang, Xiaochun Chen, Xiaoman Dai · 2025 · Biology of Sex Differences
74. In Vitro Human Blood-Brain Barrier Model for Drug Permeability Testing
    Ece Bayır, Aylin Şendemir · 2021 · Methods in molecular biology
75. Transport Characteristics of 6-Mercaptopurine in Brain Microvascular Endothelial Cells Derived From Human Induced Pluripotent Stem Cells
    Toshiki Kurosawa, Yuma Tega, Daiki Sako, Tatsuki Mochizuki, Tomoko Yamaguchi, Kenji Kawabata, Katsuhisa Inoue, Naoki Ito, Hiroyuki Kusuhara, Yoshiharu Deguchi · 2021 · Journal of Pharmaceutical Sciences
76. Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders
    Myrthe J. Ottenhoff, Lianne C. Krab, Ype Elgersma · 2020 · eNeuro
77. Crossing the Borders: the amino acid transporter LAT1 (SLC7A5) in the Blood-Brain Barrier.
    Mariafrancesca Scalise, Raffaella Scanga, Lara Console, M. Galluccio, Flaviana Marzano, Andrea Magrì, Lorena Pochini, C. Indiveri · 2025 · Neurochemistry International
78. Air pollution exposure increases ABCB1 and ASCT1 transporter levels in mouse cortex
    Elena Puris, Liudmila Saveleva, Veronika Górová, Petra Vartiainen, Miika Kortelainen, Heikki Lamberg, Olli Sippula, Tarja Malm, Pasi Jalava, Seppo O. K. Auriola et al. · 2022 · Environmental Toxicology and Pharmacology
79. Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration
    Takayuki Miura, Masanori Tachikawa, Hideo Ohtsuka, Koji Fukase, Shun Nakayama, Naoaki Sakata, Fuyuhiko Motoi, Takeshi Naitoh, Yu Katayose, Yasuo Uchida et al. · 2017 · Journal of Pharmaceutical Sciences
80. Using miniature brain implants in rodents for novel drug discovery
    Ben Waldau · 2019 · Expert Opinion on Drug Discovery
81. Mechanistic Multilayer Quantitative Model for Nonlinear Pharmacokinetics, Target Occupancy and Pharmacodynamics (PK/TO/PD) Relationship of D-Amino Acid Oxidase Inhibitor, TAK-831 in Mice
    Tomoki Yoneyama, Sho Sato, Andy P. Sykes, Rosa L. Fradley, Stuart Stafford, Shyam Bechar, Eimear Howley, Toshal R. Patel, Yoshihiko Tagawa, Toshiya Moriwaki et al. · 2020 · Pharmaceutical Research
82. Mouse embryonic stem cell-derived blood–brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis
    Anna Jezierski, Jez Huang, Arsalan S. Haqqani, Julie Haukenfrers, Ziying Liu, Ewa Baumann, Caroline Sodja, Claudie Charlebois, Christie E. Delaney, Alexandra T. Star et al. · 2023 · Fluids and Barriers of the CNS
83. Transporter expressions as part of required scaling factor to support in vitro in vivo extrapolation for blood-brain barrier drug permeability
    Zubida M. Al‐Majdoub, Jonathan Cheong, Kunihiko Mizuno, Janita Hogan, Tom De Bruyn, Anne Kanta, Jingjing Guo, Cornelis E. C. A. Hop, Mike Zientek, Aleksandra Galetin et al. · 2025 · European Journal of Pharmaceutical Sciences
84. Altering distribution profile of palbociclib by its prodrugs
    Juulia Järvinen, Ahmed B. Montaser, Santosh Kumar Adla, Jukka Leppänen, Marko Lehtonen, Kati‐Sisko Vellonen, Tuomo Laitinen, Aaro J. Jalkanen, William F. Elmquist, Juri M. Timonen et al. · 2023 · European Journal of Pharmaceutical Sciences
85. ABC transporter-dependent brain uptake of the 5-HT1B receptor radioligand [11C]AZ10419369: a comparative PET study in mouse, rat, and guinea pig
    Miklós Tóth, Jenny Häggkvist, Andrea Varrone, Sjoerd J. Finnema, Janine Doorduin, Masaki Tokunaga, Makoto Higuchi, Balázs Zoltán Gulyás, Christer Halldin · 2014 · EJNMMI Research
86. Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and rats
    Aaro J. Jalkanen, Jouni A. Ihalainen, Marko Lehtonen, Markus Forsberg, Jarkko Rautio, Kristiina M. Huttunen, Mikko Gynther · 2021 · International Journal of Pharmaceutics
87. Investigation of the role and quantitative impact of breast cancer resistance protein on drug distribution into brain and CSF in rats
    Yuki Katagiri, Hiroko Kawaguchi, Koji Umemura, Jun Tadano, Izuru Miyawaki, Mikihisa Takano · 2021 · Drug Metabolism and Pharmacokinetics
88. Blood-Arachnoid Barrier as a Dynamic Physiological and Pharmacological Interface Between Cerebrospinal Fluid and Blood
    Yasuo Uchida, Ryohei Goto, Takuya Usui, Masanori Tachikawa, Tetsuya Terasaki · 2022 · AAPS advances in the pharmaceutical sciences series
89. Role of microRNAs in the regulation of blood-brain barrier function in ischemic stroke and under hypoxic conditions in vitro
    Aili Sun, Kinga G. Blecharz-Lang, Andrzej Małecki, Patrick Meybohm, Marta Maria Nowacka-Chmielewska, Małgorzata Burek · 2022 · Frontiers in Drug Delivery
90. Humanization of the blood–brain barrier transporter ABCB1 in mice disrupts genomic locus — lessons from three unsuccessful approaches
    Markus Krohn, Thomas Wanek, Marie‐Claude Menet, Andreas Noack, Xavier Declèves, Oliver Langer, Wolfgang Löscher, Jens Pahnke · 2018 · European Journal of Microbiology and Immunology
91. Inflammation-Induced Attenuation of Prostaglandin D2 Elimination across Rat Blood–Brain Barrier: Involvement of the Downregulation of Organic Anion Transporter 3 and Multidrug Resistance-Associated Protein 4
    Shin‐ichi Akanuma, Kahori Hashimoto, Yukiko Yoshida, Yoshiyuki Kubo, Ken‐ichi Hosoya · 2020 · Biological and Pharmaceutical Bulletin
92. Considerations in Kp,uu,brain-based Strategy for Selecting CNS-targeted Drug Candidates with Sufficient Target Coverage and Substantial Pharmacodynamic Effect
    Ling Zou, Huan‐Chieh Chien, Devendra Pade, Yanfei Li, Minhkhoi Nguyen, Ravi Kanth Bhamidipati, Zhe Wang, Osatohanmwen Jessica Enogieru, Jan L. Wahlstrom · 2025 · The AAPS Journal
93. A Prediction Method for P-glycoprotein–Mediated Drug–Drug Interactions at the Human Blood–Brain Barrier From Blood Concentration–Time Profiles, Validated With PET Data
    Akihiro Matsuda, Rudolf Karch, Martin Bauer, Alexander Traxl, Markus Alexander Zeitlinger, Oliver Langer · 2017 · Journal of Pharmaceutical Sciences
94. Automated Protein Localization of Blood Brain Barrier Vasculature in Brightfield IHC Images
    Rajath Elias Soans, Diane C Lim, Brendan T Keenan, Allan I Pack, James Shackleford · 2016 · PLoS ONE
95. Human‐BasedIn VitroBrain Endothelial Cell Models
    Hannah K. Wilson, Eric V. Shusta · 2015
96. BBB-Permeable PROTACs: Where Do We Stand?
    Serena Francisco, Giulia Apprato, Matteo Rossi Sebastiano, Giuseppe Ermondi, Giulia Caron · 2026 · ACS Medicinal Chemistry Letters
97. Development and Functional Evaluation of MDR1-expressing Microvascular Endothelial-like Cells Derived from Human iPS Cells as an In vitro Blood-brain Barrier Model
    Tomoko Yamaguchi, Daiki Sako, Toshiki Kurosawa, Misae Nishijima, Ayaka Miyano, Yoshiyuki Kubo, Sumio Ohtsuki, Kenji Kawabata, Yoshiharu Deguchi · 2023 · Journal of Pharmaceutical Sciences
98. Do P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier impact morphine brain distribution?
    Berfin Gülave, Ariel Lesmana, Elizabeth C. M. de Lange, J. G. Coen van Hasselt · 2025 · Journal of Pharmacokinetics and Pharmacodynamics
99. Development of a non-human primate model to support CNS translational research: Demonstration with D-amphetamine exposure and dopamine response
    Joost H.A. Folgering, Minha Choi, Christina Schlumbohm, Marcel M. van Gaalen, Robert E. Stratford · 2019 · Journal of Neuroscience Methods
100. Does nonlinear blood-brain barrier transport matter for (lower) morphine dosing strategies?
     Berfin Gülave, Divakar Budda, Mohammed A. A. Saleh, J. G. Coen van Hasselt, Elizabeth C. M. de Lange · 2023 · European Journal of Pharmaceutical Sciences